Meihua International Medical Technologies Co Ltd (MHUAF)
OTHER OTC:MHUAF
Top Page
Meihua International Medical Technologies Co Ltd
(OTC:MHUAF)
Select Model
Select Model
Rating:65Neutral
Price Target:
$12.00
▲(100.00% Upside)
Action:UpgradedDate:01/28/26
The score is driven primarily by solid financial performance (strong operating margins and low leverage) tempered by inconsistent free cash flow. Technicals detract due to weak longer-term trend signals and negative MACD despite stretched momentum readings, while the very low P/E supports the overall score.
Positive Factors
Strong Operating Margins
Sustained strong EBIT/EBITDA and stable gross margins indicate durable operating efficiency and pricing power in medical devices. This supports reinvestment in R&D and manufacturing, cushions against input cost shocks, and underpins long‑term profitability even with cyclical demand.
Negative Factors
Declining Revenue & EPS
Negative topline and EPS trends suggest persistent demand or pricing pressures and weaken internal cash generation prospects. Continued declines can erode scale advantages, constrain R&D and commercial investment, and make margin maintenance harder across coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Operating Margins
Sustained strong EBIT/EBITDA and stable gross margins indicate durable operating efficiency and pricing power in medical devices. This supports reinvestment in R&D and manufacturing, cushions against input cost shocks, and underpins long‑term profitability even with cyclical demand.
Read all positive factors
Meihua International Medical Technologies Co Ltd (MHUAF) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$6.30M
Dividend YieldN/A
Average Volume (3M)258.45K
Price to Earnings (P/E)1.0
Beta (1Y)61.85
Revenue Growth-4.99%
EPS Growth-19.10%
CountryUS
Employees619
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)9.86
Shares Outstanding857,914
10 Day Avg. Volume415,554
30 Day Avg. Volume258,455
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)0.06
Price to Sales (P/S)0.10
P/FCF Ratio0.65
Enterprise Value/Market Cap0.06
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit0.01
Enterprise Value/Ebitda0.03
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Meihua International Medical Technologies Co Ltd Business Overview & Revenue Model
Company Description
Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People's Republic of China. The company offers Class I disposable medical devices, including disposable me...
How the Company Makes Money
MHUA generates revenue through multiple key streams, primarily from the sale of its medical devices and equipment to hospitals, clinics, and healthcare providers. The company leverages a direct sales model coupled with distribution partnerships to...
Meihua International Medical Technologies Co Ltd Financial Statement Overview
Summary
Income Statement
75
Positive
Balance Sheet
70
Positive
Cash Flow
65
Positive
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 89.55M | 96.91M | 97.10M | 103.35M | 104.04M | 89.06M |
| Gross Profit | 30.64M | 33.30M | 33.09M | 38.10M | 39.81M | 37.16M |
| EBITDA | 12.91M | 15.70M | 15.77M | 11.65M | 27.03M | 24.39M |
| Net Income | 9.27M | 10.84M | 11.63M | 6.24M | 20.95M | 19.05M |
Balance Sheet | ||||||
| Total Assets | 190.58M | 186.24M | 171.92M | 163.58M | 136.86M | 106.05M |
| Cash, Cash Equivalents and Short-Term Investments | 15.55M | 15.96M | 16.93M | 26.74M | 8.15M | 7.19M |
| Total Debt | 11.45M | 7.95M | 7.33M | 6.81M | 5.18M | 3.22M |
| Total Liabilities | 25.64M | 27.26M | 25.08M | 24.90M | 29.09M | 21.31M |
| Stockholders Equity | 164.95M | 158.98M | 146.33M | 138.12M | 106.81M | 84.74M |
Cash Flow | ||||||
| Free Cash Flow | 3.59M | 14.50M | -2.41M | -11.86M | -904.89K | -10.79M |
| Operating Cash Flow | 3.72M | 14.64M | 2.28M | -9.16M | -54.66K | 5.33M |
| Investing Cash Flow | -8.91M | -20.42M | -12.46M | -8.62M | -833.82K | -16.09M |
| Financing Cash Flow | 3.39M | 6.21M | 706.13K | 37.25M | 1.86M | 1.71M |
Meihua International Medical Technologies Co Ltd Technical Analysis
Negative
6.00
Price Trends
9.02
Negative
8.74
Negative
23.19
Negative
Market Momentum
-0.28
Positive
35.54
Neutral
54.06
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MHUAF, the sentiment is Negative. The current price of 6 is below the 20-day moving average (MA) of 8.22, below the 50-day MA of 9.02, and below the 200-day MA of 23.19, indicating a bearish trend. The MACD of -0.28 indicates Positive momentum. The RSI at 35.54 is Neutral, neither overbought nor oversold. The STOCH value of 54.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MHUAF.
Meihua International Medical Technologies Co Ltd Risk Analysis
Meihua International Medical Technologies Co Ltd disclosed 80 risk factors in its most recent earnings report. Meihua International Medical Technologies Co Ltd reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Meihua International Medical Technologies Co Ltd Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $6.30M | 1.01 | 5.90% | ― | -4.99% | -19.10% | |
54 Neutral | $28.58M | -1.12 | -85.01% | ― | -16.59% | 43.20% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | $1.42M | -2.02 | ― | ― | ― | ― | |
43 Neutral | $1.26M | -0.18 | ― | ― | ― | 60.83% | |
42 Neutral | $7.06M | -0.73 | -74.10% | ― | 53.22% | 72.69% |
* Healthcare Sector Average
MHUAF
Meihua International Medical Technologies Co Ltd
7.34
-24.66
-77.06%
EKSO
EKSO BIONICS
8.02
2.60
47.97%
GCTK
GlucoTrack
0.65
-9.55
-93.63%
LUCY
Innovative Eyewear, Inc.
1.12
-3.83
-77.37%
WOK
WORK Medical Technology Group LTD
1.16
-3,898.84
-99.97%
Meihua International Medical Technologies Co Ltd Corporate Events
Meihua International Medical Technologies Locks Up Recent Offshore Private Placement Investors for 12 Months
Jan 23, 2026
On January 22, 2026, Meihua International Medical Technologies announced that investors in two recent offshore equity financings agreed to a 12‑month lock-up on their holdings, limiting secondary market sales and registrations. The company h...
Meihua International Medical Technologies Replaces Auditor With Li CPA LLC
Jan 7, 2026
On December 26, 2025, Meihua International Medical Technologies Co., Ltd., a China-based medical devices and healthcare products supplier, dismissed Kreit Chiu CPA LLP as its independent registered public accounting firm and appointed Li CPA LLC ...
Meihua International Medical Technologies Completes December Private Placement
Dec 16, 2025
Meihua International Medical Technologies Co., Ltd. recently completed a private placement of 120,000 class A ordinary shares at $11 per share, raising $1.32 million. This follows a previous offering in October 2025, where the company issued 40 mi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.